4D Molecular Therapeutics, Inc. Common Stock
FDMT Real Time Price USDRecent trades of FDMT by members of U.S. Congress
|
Name
|
Type
|
Shares
|
Price
|
Shares Held
|
Date
|
Reported
|
|---|
|
Investor
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
|
Investor
|
Type
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
Recently reported changes by institutional investors
Quarterly net insider trading by FDMT's directors and management
* Insider trading data parsed from SEC Form 4 filings by Quiver Quantitative. Sign up for the Quiver API for real-time access.
- 1M
- 3M
- 6M
- YTD
- 1Y
- 2Y
- 5Y
- MAX
About
Key Metrics
Return (1d)
Return (30d)
Return (1Y)
CAGR (Total)
Max Drawdown
Beta
Alpha
Sharpe Ratio
Win Rate
Average Win
Average Loss
Annual Volatility
Annual Std Dev
Information Ratio
Treynor Ratio
Total Trades
Metrics Definitions
-
Alpha
Measures a portfolio's risk-adjusted performance against that of its benchmark
Learn More -
Annual Standard Deviation
Measures how much the portfolio's total return varies from its mean or average.
Learn More -
Annual Volatility
A statistical measure of the dispersion of returns for the portfolio.
Learn More -
Average Win
The average return (%) for trades that resulted in a positive return.
-
Average Loss
The average return (%) for trades that resulted in a negative return.
-
Beta
A measure of the volatility of the portfolio compared to the market as a whole.
Learn More -
CAGR
CAGR (Compounded Annual Growth Rate), is the historical annualized rate of return for an investment strategy, throughout the backtest period.
Learn More -
Information Ratio
A measurement of portfolio returns beyond the returns of its benchmark compared to the volatility of those returns.
Learn More -
Max Drawdown
the maximum observed loss from a peak to a trough of a portfolio, before a new peak is attained.
Learn More -
Sharpe Ratio
The Sharpe Ratio is a measure of historical risk-adjusted return, which quantifies the amount of return that an investor received per unit of risk.
Learn More -
Total Trades
The total number of trades made by this strategy.
-
Treynor Ratio
Attempts to measure how successful an investment is in providing compensation to investors for taking on investment risk.
Learn More -
Win Rate
The percentage of total trades that resulted in a positive return.
Be the first to see our newest insights and key updates across all datasets.
Government lobbying spending instances
Estimated quarterly lobbying spending
FDMT Revenue by Segment or Geography
New patents grants
-
Patent Title: Adeno-associated virus variant capsids and methods of use thereof Dec. 12, 2023
-
Patent Title: Adeno-associated variants, formulations and methods for pulmonary delivery Nov. 07, 2023
-
Patent Title: Adeno-associated virus variant capsids and use for inhibiting angiogenesis Sep. 26, 2023
-
Patent Title: Treatments for retinal disease Sep. 26, 2023
-
Patent Title: Treatments for retinal disease Feb. 14, 2023
-
Patent Title: Codon optimized rep1 genes and uses thereof Dec. 13, 2022
-
Patent Title: Adeno-associated variants, formulations and methods for pulmonary delivery Nov. 15, 2022
-
Patent Title: Adeno-associated virus variant capsids and methods of use thereof Aug. 23, 2022
-
Patent Title: Adeno-associated virus variant capsids and methods of use thereof Jun. 21, 2022
-
Patent Title: Codon optimized rep1 genes and uses thereof Jun. 14, 2022
-
Patent Title: Codon optimized rpgrorf15 genes and uses thereof May. 31, 2022
-
Patent Title: Codon optimized gla genes and uses thereof Dec. 14, 2021
-
Patent Title: Method of using adeno-associated virus with variant capsid Nov. 23, 2021
-
Patent Title: Adeno-associated virus variant capsids and methods of use thereof Nov. 09, 2021
-
Patent Title: Adeno-associated virus variant capsids and methods of use thereof Sep. 14, 2021
Federal grants, loans, and purchases
Estimated quarterly amount awarded from public contracts
Recent insights relating to FDMT
Recent picks made for FDMT stock on CNBC
ETFs with the largest estimated holdings in FDMT
- ... Highest Price Target
- ... Median Price Target
- ... Lowest Price Target
|
Analyst
|
Firm
|
Current
|
Previous
|
Date
|
|---|
- Is $FDMT stock a Buy, Sell, or Hold?
- What is the price target for $FDMT stock?
* Analyst consensus is not financial advice. Please see our data disclaimers .
|
Shareholder
|
Shares Held
|
|---|
- Who owns $FDMT stock?
- Who owns the most shares of $FDMT stock?
- What funds own $FDMT stock?
* These are estimates based on data taken from SEC filings. There may be inaccuracies due to parsing errors, accidental double-counting, incorrect classification of indirectly owned shares, or any other number of issues.
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.Sign Up to view FDMT Smart Score
See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.
Example:
The Bulls Say summary highlights positive aspects of the stock.
The Bears Say summary points out potential risks and negative aspects of the stock.